Business Wire

SES

28.4.2021 08:52:11 CEST | Business Wire | Press release

Share
SES’s Next-Gen NGSO System Readies for Launch with 8 Initial O3b mPOWER Satellite Ground Stations

SES announced today that it has signed agreements with key infrastructure service providers around the world to build its eight initial O3b mPOWER satellite ground stations. Construction has already started on these advanced technology satellite ground stations, which will become operational in the second half of this year. The eight sites will provide telemetry, tracking and control capabilities to enable SES’s management of the constellation. They will also be leveraged to raise the satellites into the right orbit after the scheduled launches.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210427006193/en/

As previously announced, two of the satellite ground stations are located at Dubbo, NSW, Australia (operated by Pivotel) and Thermopylae, Greece (operated by OTE) . Other locations include Merredin, Perth, Australia; Phoenix, Arizona, US; Chile; the United Arab Emirates; Senegal as well as SES’s own satellite ground station in Hawaii. Four out of the eight sites will be co-located and operated with Microsoft’s Azure data centres ; the one-hop connectivity to the cloud from remote sites will provide O3b mPOWER customers the ability to optimise business operations with significant flexibility and agility.

O3b mPOWER is SES’s next-generation Medium Earth Orbit (MEO) system. Building on the success of O3b, each of the 11 high-throughput, low-latency O3b mPOWER satellites will deliver high-speed connectivity services from tens of megabits to multiple gigabits per second, providing fibre-like connectivity to customers globally.

The O3b mPOWER satellite ground stations have many technically advanced features compared to the existing O3b satellite ground station. They include a new generation of fast-install 5.5-metre carbon fibre antennas which can be installed without the need for expensive and time-consuming photogrammetry. In addition, they will utilise energy-efficient solid-state power amplifiers, and a low electrical load for the antenna control unit (ACU).

The satellite ground stations will use SES’s gateway management system for automated operations and handovers, which will be tightly integrated with SES’s unique resource management capability, Adaptive Resource Control (ARC) and other SES software sub-systems. With this configuration, SES will dynamically manage and optimise space and ground resources to meet the changing needs of its customers. These combined technology advances result in improved efficiency and lower total cost of ownership.

The first three O3b mPOWER satellites are scheduled for launch in the third quarter of this year, with the next three in the first quarter of 2022. After orbit raising, O3b mPOWER will start delivering services in the third quarter of 2022.

Stewart Sanders, Executive Vice President of Technology and O3b mPOWER programme manager at SES, said, “We are thrilled to have chosen these eight locations and construction is underway. We are also deep in discussions with several telco players and operators who are keen to have their own O3b mPOWER satellite ground station. This is particularly exciting, as it means that SES’s provision of a core network of command, control and data gateways will be augmented with a number of customer satellite ground stations; satellite ground stations provisioned according to our customer needs, with regards to location, size and infrastructure requirements. We expect a number of these customer satellite ground stations to include virtualised installations of the cloud at the edge of the deployed networks, thus improving the end-user experience.”

Follow us on:

Read our Blogs >

Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,200 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/SES.Satellites/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release

Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early

Unpack ’26 sommerrejsetrends: Flere vælger indenlandske rejser, når de tænker mere bevidst over deres rejsevalg21.5.2026 12:35:00 CEST | Pressemeddelelse

Rejsebranchens førende databrevne trendrapport lancerer sin første sommerudgave nogensinde – Unpack ’26 Summer: The Trends in Travel I dag har Hotels.com udgivet Unpack ’26 Summer: The Trends in Travel, den nyeste udgave af virksomhedens førende trendrapport i rejsebranchen, som viser, hvordan rejseadfærd former sommerens rejsevalg. Efterspørgslen på indenlandske rejser præger sommerens ferieplanlægning. Interessen på sociale medier for indenlandske ferier er globalt steget med 77% sammenlignet med sidste år, og 44% af danske rejsende planlægger en indenlandsk rejse denne sommer*. Fra store sportsbegivenheder og koncerter til rejser inspireret af film og tv bygger Unpack ’26 Summer på indsigter fra den årlige hovedrapport Unpack ’26: The Trends in Travel™ for at fremhæve, hvor rejsende tager hen denne sommer. HHver tendens bygger på førstehåndsdata fra Hotels.com® kombineret med indsigter fra rejsende og overvågning af sociale medier. “Denne sommer bliver der stadig rejst – men på nye

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 12:30:00 CEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows21.5.2026 12:00:00 CEST | Press release

Aker BP joins as the first customer to scale agent-to-agent operations through a new generation of industrial agentic workflow applications Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028. Transforming Data into Actionable Business Value By breaking down traditional data silos and shifting

BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts21.5.2026 12:00:00 CEST | Press release

Long-term and real-world evidence reinforce BRUKINSA as the foundation of CLL treatmentThree oral presentations at ASCO highlight rapid acceleration of BeOne’s solid tumor pipeline BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and solid tumors have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29–June 2, Chicago) and the 2026 European Hematology Association (EHA) Congress (June 11–14, Stockholm). Continuing to raise the bar in CLL At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell malignancies. The data emphasize impressive long-term outcomes, durability across patient populations, and a disciplined approach to advancing future regimens. Collectively, these data undersco

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye